Financial Ratios Jiangsu Nata Opto-electronic Material Co., Ltd.
Equities
300346
CNE100001K48
Commodity Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.00 CNY | -2.79% |
|
+4.63% | +42.19% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.57 | 2.08 | 2.69 | 2.73 | 5.29 | |||||
Return on Total Capital | 0.85 | 3.17 | 3.84 | 3.78 | 7.67 | |||||
Return On Equity % | 7.36 | 9.28 | 10.18 | 10.25 | 11.08 | |||||
Return on Common Equity | 6.86 | 8.42 | 9.26 | 9.75 | 9.64 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.37 | 36.98 | 38.94 | 41.81 | 38.87 | |||||
SG&A Margin | 24.34 | 18.42 | 18.3 | 15.33 | 12.09 | |||||
EBITDA Margin % | 16.84 | 27.02 | 26.66 | 30.16 | 36.56 | |||||
EBITA Margin % | 5.68 | 15.08 | 15.66 | 16.74 | 23.85 | |||||
EBIT Margin % | 3.77 | 11.56 | 12.91 | 14.18 | 21.98 | |||||
Income From Continuing Operations Margin % | 18.27 | 18.6 | 16.11 | 16.09 | 15.81 | |||||
Net Income Margin % | 14.63 | 13.84 | 11.81 | 12.42 | 11.52 | |||||
Net Avail. For Common Margin % | 14.63 | 13.84 | 11.81 | 12.42 | 11.52 | |||||
Normalized Net Income Margin | 6.31 | 2.1 | 3.56 | 4.39 | 9.59 | |||||
Levered Free Cash Flow Margin | -53.86 | -45.38 | -26.98 | 21 | 22.68 | |||||
Unlevered Free Cash Flow Margin | -52.92 | -44.45 | -25.72 | 23.22 | 24.15 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.24 | 0.29 | 0.33 | 0.31 | 0.38 | |||||
Fixed Assets Turnover | 0.68 | 0.76 | 0.91 | 0.89 | 1.24 | |||||
Receivables Turnover (Average Receivables) | 2.16 | 2.72 | 3.48 | 3.28 | 3.19 | |||||
Inventory Turnover (Average Inventory) | 2.9 | 2.99 | 2.56 | 1.83 | 2.17 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.11 | 2.26 | 3.36 | 2.78 | 2.36 | |||||
Quick Ratio | 1.71 | 1.82 | 2.64 | 2.2 | 1.9 | |||||
Operating Cash Flow to Current Liabilities | 0.25 | 0.31 | 0.29 | 0.47 | 0.37 | |||||
Days Sales Outstanding (Average Receivables) | 169.12 | 134.38 | 104.82 | 111.42 | 114.58 | |||||
Days Outstanding Inventory (Average Inventory) | 126.39 | 122.02 | 142.35 | 199.91 | 168.88 | |||||
Average Days Payable Outstanding | 180.61 | 166.78 | 123.7 | 158.15 | 190.9 | |||||
Cash Conversion Cycle (Average Days) | 114.9 | 89.62 | 123.46 | 153.18 | 92.56 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 11.87 | 15.2 | 48.55 | 50.29 | 8.62 | |||||
Total Debt / Total Capital | 10.61 | 13.19 | 32.68 | 33.46 | 7.94 | |||||
LT Debt/Equity | 3.35 | 5.44 | 43 | 43.09 | 3.11 | |||||
Long-Term Debt / Total Capital | 2.99 | 4.72 | 28.95 | 28.67 | 2.87 | |||||
Total Liabilities / Total Assets | 40.94 | 42.98 | 50.42 | 52.68 | 38.41 | |||||
EBIT / Interest Expense | 2.5 | 7.77 | 6.41 | 4.01 | 9.33 | |||||
EBITDA / Interest Expense | 11.17 | 18.22 | 13.28 | 8.54 | 15.55 | |||||
(EBITDA - Capex) / Interest Expense | -47.52 | -27.1 | -3.48 | 5.72 | 11.91 | |||||
Total Debt / EBITDA | 1.87 | 1.35 | 3.03 | 2.65 | 0.4 | |||||
Net Debt / EBITDA | -3.75 | -2.95 | -0.88 | -1.09 | -2.28 | |||||
Total Debt / (EBITDA - Capex) | -0.44 | -0.91 | -11.55 | 3.96 | 0.52 | |||||
Net Debt / (EBITDA - Capex) | 0.88 | 1.99 | 3.34 | -1.62 | -2.98 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 85.13 | 65.46 | 60.62 | 7.72 | 38.08 | |||||
Gross Profit, 1 Yr. Growth % | 78.47 | 68.23 | 69.12 | 3.63 | 28.37 | |||||
EBITDA, 1 Yr. Growth % | 19.15 | 164.65 | 58.28 | 21.59 | 36.04 | |||||
EBITA, 1 Yr. Growth % | -30.78 | 335.41 | 66.32 | 14.82 | 38.98 | |||||
EBIT, 1 Yr. Growth % | -48.36 | 405.37 | 79.33 | 18.35 | 43.94 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 76.13 | 68.54 | 39.09 | 7.58 | 35.72 | |||||
Net Income, 1 Yr. Growth % | 58.18 | 56.55 | 37.07 | 13.26 | 28.15 | |||||
Normalized Net Income, 1 Yr. Growth % | 2.81 | -57.78 | 172.37 | 33.09 | 51.97 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 55.07 | 54.54 | 30.73 | 14.72 | 25.63 | |||||
Accounts Receivable, 1 Yr. Growth % | 37.58 | 27.23 | 17.99 | 17.45 | 56.78 | |||||
Inventory, 1 Yr. Growth % | 20.54 | 90.26 | 77 | 25.61 | 19.5 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 40.91 | 52.23 | 21.9 | 1.04 | -2.1 | |||||
Total Assets, 1 Yr. Growth % | 20.83 | 55.42 | 27.92 | 7.93 | 13.13 | |||||
Tangible Book Value, 1 Yr. Growth % | -9.12 | 51.88 | 17.89 | 8.3 | 72.35 | |||||
Common Equity, 1 Yr. Growth % | 8.13 | 45.35 | 10.48 | 4.85 | 53.07 | |||||
Cash From Operations, 1 Yr. Growth % | -54.23 | 105.4 | -12.49 | 130.59 | 18.69 | |||||
Capital Expenditures, 1 Yr. Growth % | 92.17 | 26.04 | -19.62 | -68.14 | 18.78 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -218.57 | 43.75 | -4.52 | -183.87 | 23.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -215.66 | 43.4 | -7.07 | -197.24 | 21.19 | |||||
Dividend Per Share, 1 Yr. Growth % | 33.33 | 25.39 | 81.62 | 21.44 | 76.55 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 61.48 | 75.02 | 63.02 | 31.54 | 21.96 | |||||
Gross Profit, 2 Yr. CAGR % | 46.33 | 73.27 | 68.67 | 39.86 | 15.34 | |||||
EBITDA, 2 Yr. CAGR % | 63.74 | 77.85 | 104.8 | 38.86 | 42.68 | |||||
EBITA, 2 Yr. CAGR % | 68.25 | 74.41 | 169.42 | 38.42 | 50.3 | |||||
EBIT, 2 Yr. CAGR % | 58.17 | 61.87 | 201.05 | 45.68 | 59.18 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 39.96 | 72.29 | 53.11 | 22.32 | 20.83 | |||||
Net Income, 2 Yr. CAGR % | 30.31 | 57.36 | 46.49 | 24.59 | 20.47 | |||||
Normalized Net Income, 2 Yr. CAGR % | 19.81 | -24.79 | 7.23 | 90.39 | 100.26 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 31.21 | 55.86 | 41.75 | 22.47 | 20.05 | |||||
Accounts Receivable, 2 Yr. CAGR % | 48.23 | 32.31 | 22.52 | 17.72 | 35.7 | |||||
Inventory, 2 Yr. CAGR % | 9.62 | 51.44 | 83.51 | 49.11 | 22.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 104.96 | 46.46 | 36.22 | 10.98 | -0.54 | |||||
Total Assets, 2 Yr. CAGR % | 34.68 | 37.04 | 41 | 17.51 | 10.5 | |||||
Tangible Book Value, 2 Yr. CAGR % | -11.4 | 17.49 | 33.81 | 12.99 | 36.62 | |||||
Common Equity, 2 Yr. CAGR % | 5.43 | 25.36 | 26.72 | 7.63 | 26.69 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.89 | -3.04 | 34.07 | 42.05 | 65.43 | |||||
Capital Expenditures, 2 Yr. CAGR % | 233.08 | 55.63 | 0.65 | -49.4 | -38.48 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -25.43 | 28.57 | 17.16 | -10.51 | 11.82 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -26.08 | 26.79 | 15.44 | -4.94 | 18.18 | |||||
Dividend Per Share, 2 Yr. CAGR % | 22.36 | 29.3 | 50.91 | 48.51 | 46.43 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 49.74 | 62.8 | 70.08 | 41.99 | 33.68 | |||||
Gross Profit, 3 Yr. CAGR % | 44.15 | 53.29 | 71.88 | 48.74 | 35.92 | |||||
EBITDA, 3 Yr. CAGR % | 42.55 | 92.35 | 71.15 | 72.24 | 47.8 | |||||
EBITA, 3 Yr. CAGR % | 40.41 | 131.71 | 71.8 | 102.97 | 55.63 | |||||
EBIT, 3 Yr. CAGR % | 34.22 | 133.27 | 67.49 | 120.54 | 65.63 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 44.8 | 48.9 | 60.43 | 36.11 | 26.63 | |||||
Net Income, 3 Yr. CAGR % | 37 | 38.53 | 50.29 | 34.44 | 25.76 | |||||
Normalized Net Income, 3 Yr. CAGR % | 35.7 | -7.57 | 15.49 | 15.24 | 121.88 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 38.02 | 39.19 | 46.72 | 32.1 | 23.51 | |||||
Accounts Receivable, 3 Yr. CAGR % | 38.49 | 40.87 | 27.35 | 20.81 | 29.52 | |||||
Inventory, 3 Yr. CAGR % | 18.08 | 31.73 | 59.52 | 61.73 | 38.5 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 65.21 | 85.61 | 37.77 | 23.31 | 6.44 | |||||
Total Assets, 3 Yr. CAGR % | 25.71 | 41.27 | 33.93 | 28.99 | 16.03 | |||||
Tangible Book Value, 3 Yr. CAGR % | -8.67 | 6.04 | 17.62 | 24.7 | 30.07 | |||||
Common Equity, 3 Yr. CAGR % | 2.83 | 17.34 | 20.19 | 18.96 | 21.04 | |||||
Cash From Operations, 3 Yr. CAGR % | 78.24 | 26.36 | -6.3 | 60.63 | 33.79 | |||||
Capital Expenditures, 3 Yr. CAGR % | 167.39 | 140.92 | 24.87 | -31.41 | -32.75 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 208.13 | -8.13 | 16.43 | 4.81 | 6.08 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 206.32 | -8.76 | 14.32 | 9.02 | 9.08 | |||||
Dividend Per Share, 3 Yr. CAGR % | -5.36 | 23.36 | 44.81 | 40.37 | 57.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 37.66 | 57.58 | 54.92 | 49.49 | 48.9 | |||||
Gross Profit, 5 Yr. CAGR % | 30.89 | 62.13 | 53.5 | 47.77 | 49.78 | |||||
EBITDA, 5 Yr. CAGR % | 46.82 | 97.74 | 64.88 | 68.89 | 59.2 | |||||
EBITA, 5 Yr. CAGR % | 60.92 | 37.56 | 82.56 | 88.64 | 62.96 | |||||
EBIT, 5 Yr. CAGR % | 29.91 | 28.04 | 85.57 | 93.23 | 64.11 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.31 | 103.6 | 48.07 | 37.64 | 43.23 | |||||
Net Income, 5 Yr. CAGR % | 14.37 | 78.35 | 40.72 | 32.78 | 37.56 | |||||
Normalized Net Income, 5 Yr. CAGR % | 20.42 | 27.6 | 30.22 | 23.41 | 43.94 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.89 | 79.19 | 39.88 | 32.1 | 35.41 | |||||
Accounts Receivable, 5 Yr. CAGR % | 28.26 | 37.39 | 31.87 | 31.11 | 30.63 | |||||
Inventory, 5 Yr. CAGR % | 8.02 | 27.19 | 40.85 | 38.43 | 43.54 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 38.08 | 48.78 | 52.94 | 51.1 | 20.93 | |||||
Total Assets, 5 Yr. CAGR % | 15.52 | 26.45 | 31.62 | 31.24 | 24.02 | |||||
Tangible Book Value, 5 Yr. CAGR % | -4.94 | 3.44 | 6.41 | 8.77 | 24.88 | |||||
Common Equity, 5 Yr. CAGR % | 1.95 | 10.03 | 11.79 | 13.35 | 22.75 | |||||
Cash From Operations, 5 Yr. CAGR % | 35.92 | 51.28 | 59.05 | 32.42 | 17.63 | |||||
Capital Expenditures, 5 Yr. CAGR % | 67.68 | 79.5 | 80.89 | 29.06 | -5.93 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 60.81 | 88.52 | 108.01 | -9.09 | 14.56 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 60.31 | 87.74 | 106.03 | -7.25 | 15.85 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0.4 | 16.28 | 14.06 | 32.86 | 45.45 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















